Cyclo Therapeutics -CW25CYTHWPreferred / convertible
13F holders, Q3 2024 (September 30)2holders +1
1new positions
0sold out
1famous investor
$0.10avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Cyclo Therapeutics -CW25 (CYTHW) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($1K) and Bank of America Corp. ($19). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Cyclo Therapeutics -CW25
- CUSIP
- 23254X110
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $19 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 944 shares bought, net +944 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Citadel Advisors | — | Add +7.4% | 11,593 | $1K |
| Bank of America Corp. | — | New | 144 | $19 |
"% of holder's portfolio" is CYTHW's weight in each manager's 13F, not the share of Cyclo Therapeutics -CW25 the manager owns.